Evidence map›Paper›PMID 28205533›Full record

ArticleScientific reports2017

A data-driven approach for evaluating multi-modal therapy in traumatic brain injury.

Jenny Haefeli, Adam R Ferguson, Deborah Bingham, Adrienne Orr, Seok Joon Won, Tina I Lam, Jian Shi, Sarah Hawley, Jialing Liu, Raymond A Swanson and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Neurotrauma as a big-data problem.Current opinion in neurology · 2018
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Jenny HaefeliBrain and Spinal Injury Center (BASIC), Department of Neurological Surgery, University of California, San Francisco, CA, United States.
Adam R FergusonBrain and Spinal Injury Center (BASIC), Department of Neurological Surgery, University of California, San Francisco, CA, United States.
Deborah BinghamSan Francisco Veterans Affairs Medical Center, San Francisco, CA, United States.
Adrienne OrrSan Francisco Veterans Affairs Medical Center, San Francisco, CA, United States.
Seok Joon WonSan Francisco Veterans Affairs Medical Center, San Francisco, CA, United States.
Tina I LamSan Francisco Veterans Affairs Medical Center, San Francisco, CA, United States.
Jian ShiSan Francisco Veterans Affairs Medical Center, San Francisco, CA, United States.
Sarah HawleySan Francisco Veterans Affairs Medical Center, San Francisco, CA, United States.
Jialing LiuBrain and Spinal Injury Center (BASIC), Department of Neurological Surgery, University of California, San Francisco, CA, United States.
Raymond A SwansonSan Francisco Veterans Affairs Medical Center, San Francisco, CA, United States.
Stephen M MassaSan Francisco Veterans Affairs Medical Center, San Francisco, CA, United States.
University of California, San Francisco · USSan Francisco VA Medical Center · USNeurological Surgery · US

Funding

Maladaptive Plasticity in Spinal Cord Injury: Cellular MechanismsR01NS088475 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERGUSON, ADAM R · 2015 to 2019
$1.7M
Bioinformatics For Translational Spinal Cord Injury ResearchR01NS067092 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERGUSON, ADAM R · 2010 to 2014
$1.6M
Trk Ligands for Treatment of Traumatic Brain InjuryI01BX000267 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · PI MASSA, STEPHEN M. · 2009 to 2018
–
Mechanisms underlying Netrin-1-mediated functional recovery after strokeI01RX000655 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · PI LIU, JIALING · 2012 to 2015
–
BLRD VA I01 BX000267NINDS NIH HHS R01 NS067092NINDS NIH HHS R01 NS088475RRD VA I01 RX000655
6 · The paper itself

Abstract

Combination therapies targeting multiple recovery mechanisms have the potential for additive or synergistic effects, but experimental design and analyses of multimodal therapeutic trials are challenging. To address this problem, we developed a data-driven approach to integrate and analyze raw source data from separate pre-clinical studies and evaluated interactions between four treatments following traumatic brain injury. Histologic and behavioral outcomes were measured in 202 rats treated with combinations of an anti-inflammatory agent (minocycline), a neurotrophic agent (LM11A-31), and physical therapy consisting of assisted exercise with or without botulinum toxin-induced limb constraint. Data was curated and analyzed in a linked workflow involving non-linear principal component analysis followed by hypothesis testing with a linear mixed model. Results revealed significant benefits of the neurotrophic agent LM11A-31 on learning and memory outcomes after traumatic brain injury. In addition, modulations of LM11A-31 effects by co-administration of minocycline and by the type of physical therapy applied reached statistical significance. These results suggest a combinatorial effect of drug and physical therapy interventions that was not evident by univariate analysis. The study designs and analytic techniques applied here form a structured, unbiased, internally validated workflow that may be applied to other combinatorial studies, both in animals and humans.

Indexed as

Combined Modality TherapyAnimalsBehavior, AnimalBrain Injuries, TraumaticDisease Models, AnimalHumansTreatment Outcome

Identifiers

PMID28205533
PMCPMC5311970
OpenAlexW2588765690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.